| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09:00 | Enzymatica AB: Quarterly report Q3/2025: Strong development in Sweden and continued focus on international expansion | 141 | PR Newswire | LUND, Sweden, Oct. 30, 2025 /PRNewswire/ --
Third quarter
January-September
... ► Artikel lesen | |
| ENZYMATICA Aktie jetzt für 0€ handeln | |||||
| 14.10. | ENZYMATICA AB: ColdZyme launches a refreshing new flavour - Eucalyptus | 1 | Cision News | ||
| 13.10. | Enzymatica appoints Holger Lembrér as new CFO | 2 | Investing.com | ||
| 13.10. | Enzymatica beruft Holger Lembrér zum neuen CFO | 1 | Investing.com Deutsch | ||
| 13.10. | Enzymatica AB: Enzymatica appoints Holger Lembrér as new CFO | 184 | GlobeNewswire (Europe) | Enzymatica AB (publ) has appointed Holger Lembrér as new Chief Financial Officer (CFO). He will assume the position no later than April 2026 and will be part of the company's executive management team.
Holger... ► Artikel lesen | |
| 01.10. | Enzymatica AB: Enzymatica to Support Swedish Biathlon Federation as Official Supplier | 60 | GlobeNewswire (Europe) | Enzymatica is proud to announce a partnership with the Swedish Biathlon Federation, under which Enzymatica becomes an Official Supplier to the national federation.
The collaboration focuses on initiatives... ► Artikel lesen | |
| 22.08. | Enzymatica AB: Bulletin from the Extraordinary General Meeting of Enzymatica AB (publ) on 22 August 2025 | 128 | GlobeNewswire (Europe) | On 22 August 2025, the shareholders of Enzymatica AB (publ) (the "Company") held an Extraordinary General Meeting. The following principal resolutions were adopted at the Meeting.
Election of Board... ► Artikel lesen | |
| 12.08. | Enzymatica AB: Sana Alajmovic appointed new CEO of Enzymatica AB | 161 | GlobeNewswire (Europe) | The Board of Directors of Enzymatica AB (publ) has appointed Sana Alajmovic as the new Chief Executive Officer. She succeeds Claus Egstrand, who has announced that he is stepping down from his operational... ► Artikel lesen | |
| 06.08. | Notice of Extraordinary General Meeting in Enzymatica AB (publ) | 1 | Cision News | ||
| 17.07. | Quarterly report Q2/2025: Strong development in Sweden and increased international activity: Enzymatica AB | 301 | PR Newswire | LUND, Sweden, July 17, 2025
/PRNewswire/ --
Second quarter
Net sales reached SEK 8.3 (6.4) million.The operating result totaled SEK -14.9 (-13.5) million.Earnings per... ► Artikel lesen | |
| 17.07. | ENZYMATICA AB: Quarterly report Q2/2025: Strong development in Sweden and increased international activity | 3 | Cision News | ||
| 30.06. | Enzymatica AB: Enzymatica's CFO Therese Filmersson to leave her position | 130 | GlobeNewswire (Europe) | Enzymatica AB (publ) announces today that the company's Chief Financial Officer (CFO), Therese Filmersson, has decided to leave her position. The decision has been made in mutual agreement between Therese... ► Artikel lesen | |
| 26.06. | Enzymatica AB: Claus Egstrand steps down as CEO of Enzymatica | 309 | GlobeNewswire (Europe) | The CEO of Enzymatica AB, Claus Egstrand, is stepping down from his role and will join the company's Board of Directors. Recruitment of a new CEO has begun. The change will ensure long-term stability... ► Artikel lesen | |
| 07.05. | Bulletin from the annual general meeting of Enzymatica AB (publ) on May 7, 2025 | 1 | Cision News | ||
| 05.05. | ENZYMATICA AB: Enzymatica gears up for global expansion after a strong first quarter | 3 | Cision News | ||
| 29.04. | Enzymatica AB: Quarterly report Q1/2025: Enzymatica strengthens its position in home markets and focuses on international expansion | 266 | PR Newswire | LUND, Sweden, April 29, 2025 /PRNewswire/ --
First quarter
Net sales amounted to SEK 12.3 million (9.4).Operating result amounted to SEK -18.0 million (-18.4).Earnings per share... ► Artikel lesen | |
| 28.02. | Enzymatica AB: Invitation to Press Briefing - 5 March 2025 | 356 | PR Newswire | STOCKHOLM, Feb. 28, 2025 /PRNewswire/ -- In connection with the publication of results from two independent research studies on ColdZyme, Enzymatica AB invites to a digital press briefing... ► Artikel lesen | |
| 28.02. | Enzymatica AB: New independent studies show that ColdZyme addresses the root cause of respiratory infections, reducing sick days and symptoms | 417 | PR Newswire | STOCKHOLM, Feb. 28, 2025 /PRNewswire/ -- Today, results from two independent studies on the medical device ColdZyme were published in the peer-reviewed scientific journal The Journal of Physiology.... ► Artikel lesen | |
| 18.02. | Enzymatica AB: Year-end report 2024: Strong performance in core markets - preparing for international growth | 267 | PR Newswire | LUND, Sweden, Feb. 18, 2025 /PRNewswire/ --
Fourth quarter
January-December
• Net sales reached SEK 17.2 million (15.8).
• The operating result totaled SEK -13.7... ► Artikel lesen | |
| 07.11.24 | Enzymatica AB's Interim report Q3/2024: Focus on developing existing and new markets | 468 | PR Newswire | LUND, Sweden, Nov. 7, 2024 /PRNewswire/ --
Third quarter
January-September
Net sales reached SEK 12.6 (13.3) million. The operating result totaled... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 26,870 | -2,50 % | Bayer Aktie: Die Ruhe vor dem großen Ausbruch nach oben? | Die Erholungsbewegung der Bayer Aktie seit dem Doppeltief bei 18,37/18,41 Euro aus November 2024 und April 2025 wurde im Jahresverlauf deutlich gestoppt. Zwei lokale Tops im Juli bei 29,78 Euro und... ► Artikel lesen | |
| NOVO NORDISK | 43,660 | -1,69 % | GLP-1-Boom vor dem Ende? Jefferies stutzt Novo Nordisk - Underperform! | Der Höhenflug von Wegovy und Ozempic könnte bald ins Stocken geraten. Das befürchtet das Analysehaus Jefferies - und stuft die Bewertung von Novo Nordisk auf Unterperform. Das neue Kursziel verheißt... ► Artikel lesen | |
| PFIZER | 21,100 | +0,62 % | Milliardenduell mit Pfizer: Novo Nordisk greift an | Die Aktie von Novo Nordisk notiert aktuell bei 43,47 EUR und bleibt nach einem turbulenten Oktoberschluss im Fokus der Investoren. Der dänische Pharmariese, bekannt für seine Blockbuster-Medikamente... ► Artikel lesen | |
| GILEAD SCIENCES | 103,26 | +1,16 % | Ertragszahlen, Gerüchte, News - Calling USA | ||
| SANOFI | 88,37 | +0,86 % | Tagesvorschau: 24. Oktober: Finale der Berichtswoche mit Porsche, Sanofi & Co. | Bilanz-Endspurt und globale StimmungsprobenZum Wochenschluss rücken Porsche, Sanofi, Holcim und Safran in den Fokus - die europäischen Schwergewichte beschließen die Berichtssaison. Die globale Stimmung... ► Artikel lesen | |
| GSK | 20,310 | +1,96 % | JPMORGAN stuft GSK auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für GSK auf "Underweight" mit einem Kursziel von 1400 Pence belassen. Beim Kerngewinn je Aktie liege er mit seinen Schätzungen etwas... ► Artikel lesen | |
| ABBVIE | 197,40 | +1,23 % | AbbVie's ELAHERE Receives Positive Reimbursement Recommendation From Canada's Drug Agency | WASHINGTON (dpa-AFX) - AbbVie (ABBV) on Thursday said that Canada's Drug Agency (CDA-AMC) has recommended ELAHERE for reimbursement with conditions for the treatment of patients with certain... ► Artikel lesen | |
| CANOPY GROWTH | 1,086 | -0,18 % | Stocks in Play: Canopy Growth Corporation | ||
| STADA ARZNEIMITTEL | - | - | Canson Capital Partners agiert als Federführender Finanzberater von Capvest bei der Akquisition von Stada und co-investiert über seinen Merchant Banking Arm | London (ots/PRNewswire) - STADA ist die sechste Private-Equity-Transaktion, bei der Canson als Finanzberater und Co-Investor auftrittCanson Capital Partners ("Canson") freut sich bekannt zu geben, dass... ► Artikel lesen | |
| ASTRAZENECA | 142,60 | +0,11 % | Buy or Goodbye?: Volkswagen, Hensoldt, Intel und Astrazeneca - Analystenstimmen des Tages | © Foto: Britta Pedersen/zb/dpaVolkswagen, Hensoldt, Intel und Astrazeneca: Die wichtigsten Analysten-Updates im Überblick.Bernstein Research stuft Volkswagen auf "Neutral" Das US-Analysehaus Bernstein... ► Artikel lesen | |
| HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
| INNOCAN PHARMA | 11,100 | -3,48 % | Breaking News: Nur noch fünf Tage für InnoCan Pharma?! | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | CSE Bulletin: Suspensions - Blender Bites Limited, TAAT Global Alternatives Inc. | Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as... ► Artikel lesen | |
| CRONOS GROUP | 2,140 | +0,56 % | Cronos Group Inc: Cronos brings back caramel green apple edible | ||
| VIATRIS | 9,008 | +1,51 % | Collaborating to Address Antimicrobial Resistance at Viatris | NORTHAMPTON, MA / ACCESS Newswire / October 28, 2025 / Antimicrobial resistance (AMR) is a significant global health challenge impacting millions of people around the world and with the potential to... ► Artikel lesen |